Present status of the detection of antifungal resistance: the perspective from both sides of the ocean  M. Cuenca-Estrella, J.L. Rodríguez-Tudela  Clinical.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
L. Boyanova  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species  L. Bernal-Martínez, M.J. Buitrago, M.V.
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
E. Cendejas-Bueno, A. Forastiero, J. L. Rodriguez-Tudela, M
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
Virological tools to diagnose and monitor hepatitis C virus infection
Quinolone resistance among Shigella spp
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Potential risk factors for infection with Candida spp
D. Rodriguez, B. J. Park, B. Almirante, M. Cuenca-Estrella, A. M
Clinical Microbiology and Infection
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Vector control: a cornerstone in the malaria elimination campaign
J.P. Donnelly, B.E. De Pauw  Clinical Microbiology and Infection 
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts  J.L. Rodríguez-Tudela, F. Barchiesi,
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
E. Cendejas-Bueno, A. Forastiero, J. L. Rodriguez-Tudela, M
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
Uncommon opportunistic fungi: new nosocomial threats
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
Elements of design: the knowledge on which we build
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study  E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
Overview of cefixime use in community-acquired infections
Brita Bruun, Henrik Westh, Jørgen Stenderup 
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species†   C.B. Moore,
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Present status of the detection of antifungal resistance: the perspective from both sides of the ocean  M. Cuenca-Estrella, J.L. Rodríguez-Tudela  Clinical Microbiology and Infection  Volume 7, Pages 46-53 (January 2001) DOI: 10.1111/j.1469-0691.2001.tb00009.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Fig 1 Growth kinetics of 24 clinical isolates of Candida spp. (six different species). Comparison between NCCLS reference methodology (RPMI and inoculation of 103 CFU/mL) and new method, including 2% glucose and 105 CFU/mL. OD, optical density. Clinical Microbiology and Infection 2001 7, 46-53DOI: (10.1111/j.1469-0691.2001.tb00009.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.